INSIGHTS ON PHARMACEUTICAL LOGISTICS

• Top Safety Considerations In Biopharmaceutical Manufacturing

  Understanding top safety concerns, from combustible material handling and chemical exposure to HPAPIs, is the first step toward preventing accidents in biopharmaceutical manufacturing environments.

• Biopharma Supply, Reimagined: Regional, Resilient Manufacturing

  Persistent disruption is redefining biopharma supply chains. Explore how regional manufacturing, integrated risk management, and closer collaboration help build resilience and improve agility.

• Pharmaceutical Supply Chain Management Best Practices

  Explore strategies for effective supply chain management and overcoming modern supply chain challenges in the pharmaceutical industry.

• Building A Resilient Supply Chain For Your Next-Generation Peptide Therapeutic

  As peptide therapeutics continue to establish themselves as a leading technology for treating chronic indications, drug sponsors must identify reliable peptide building block suppliers to secure high-quality starting materials.

• 4 Things To Consider In Pharmaceutical Labeling

  12/11/2024

  Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options.

• Risk Mitigation For Late-Stage Clinical Assets

  6/11/2025

  Leveraging the competence and capabilities of the CDMO to bring forth innovative, flexible solutions to safeguard supply chains for their clients and, ultimately, for patients is crucial to strategic partnering.

• The Way Forward: Supply Chain Solutions

  10/24/2024

  Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions.

• Clinical, Commercial Packaging: Delivering Next-Gen Therapies

  4/7/2026

  See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

• Strengthen Pharmaceutical Supply Chains With A U.S.-Based CDMO

  6/5/2025

  While certain ingredients require sourcing abroad, partnering with a U.S.-based company that owns its manufacturing assets allows for direct oversight of product quality and supply reliability.